Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial. Ergun Y. Lancet 2024;404:337-338.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ergun Y. Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial. Lancet 2024;404:337-338.
PMID: 39067898